206 related articles for article (PubMed ID: 26235139)
1. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
Hover LD; Young CD; Bhola NE; Wilson AJ; Khabele D; Hong CC; Moses HL; Owens P
Cancer Lett; 2015 Nov; 368(1):79-87. PubMed ID: 26235139
[TBL] [Abstract][Full Text] [Related]
2. Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract][Full Text] [Related]
3. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract][Full Text] [Related]
4. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
[TBL] [Abstract][Full Text] [Related]
5. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification.
Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ
J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065
[TBL] [Abstract][Full Text] [Related]
6. DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer.
Hao J; Lee R; Chang A; Fan J; Labib C; Parsa C; Orlando R; Andresen B; Huang Y
PLoS One; 2014; 9(6):e90748. PubMed ID: 24603907
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of BMP signaling suppresses metastasis in mammary cancer.
Owens P; Pickup MW; Novitskiy SV; Giltnane JM; Gorska AE; Hopkins CR; Hong CC; Moses HL
Oncogene; 2015 May; 34(19):2437-49. PubMed ID: 24998846
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P; Owens P; Hong CC
Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling.
Wu WK; Sung JJ; Yu L; Cho CH
Biochem Biophys Res Commun; 2008 Jun; 371(2):209-14. PubMed ID: 18435911
[TBL] [Abstract][Full Text] [Related]
12. Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin.
Yoshida Y; Kurokawa T; Nishikawa Y; Orisa M; Kleinman HK; Kotsuji F
Int J Oncol; 2008 Mar; 32(3):673-81. PubMed ID: 18292945
[TBL] [Abstract][Full Text] [Related]
13. Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity.
Alsamarah A; LaCuran AE; Oelschlaeger P; Hao J; Luo Y
PLoS One; 2015; 10(7):e0132221. PubMed ID: 26133550
[TBL] [Abstract][Full Text] [Related]
14. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.
Edson MA; Nalam RL; Clementi C; Franco HL; Demayo FJ; Lyons KM; Pangas SA; Matzuk MM
Mol Endocrinol; 2010 Jun; 24(6):1251-66. PubMed ID: 20363875
[TBL] [Abstract][Full Text] [Related]
15. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma.
Hover LD; Owens P; Munden AL; Wang J; Chambless LB; Hopkins CR; Hong CC; Moses HL; Abel TW
Neuro Oncol; 2016 Jul; 18(7):928-38. PubMed ID: 26683138
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.
Yin J; Jung JE; Choi SI; Kim SS; Oh YT; Kim TH; Choi E; Lee SJ; Kim H; Kim EO; Lee YS; Chang HJ; Park JY; Kim Y; Yun T; Heo K; Kim YJ; Kim H; Kim YH; Park JB; Choi SW
Cancer Lett; 2018 Feb; 414():181-189. PubMed ID: 29154973
[TBL] [Abstract][Full Text] [Related]
20. Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/β-catenin and BMP signalling with small molecules.
Aguilar JS; Begum AN; Alvarez J; Zhang XB; Hong Y; Hao J
Biochem J; 2015 Jul; 469(2):235-41. PubMed ID: 26171831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
